Highlights Emerald Health Therapeutics, Inc. Toronto S.E.

Equities

EMH

CA29102R1064

End-of-day quote Toronto S.E. Other stock markets 03:30:00 05/05/2021 am IST			5-day change	1st Jan Change
0.235 ^CAD	-4.08%		-.--%	+27.50%

2023	C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.	CI
2022	C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.	09/23/09	CI
C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million.	14/22/14	CI
Skye Bioscience, Inc. completed the acquisition of Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others.	10/22/10	CI
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger	19/22/19	AQ
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	30/22/30	CI
Skye Bioscience Reports that CSE-listed Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement	20/22/20	MT
Certain Emerald Health Shareholders Oppose Proposed Merger with Skye Biosciences	04/22/04	MT
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	09/22/09	CI
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Skye Bioscience, Inc. entered into term sheet to acquire Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others for CAD 24.4 million.	11/22/11	CI
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	30/21/30	CI
An unknown buyer agreed to acquire Recreational and Medical Cannabis Business of Emerald Health Therapeutics, Inc.	29/21/29	CI
Emerald Health Therapeutics, Inc. and HYTN Cannabis to Launch Cannabis Beverages in Canada	03/21/03	CI
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/21/30	CI
Emerald Health Therapeutics, Inc. Launches Fuse™ Lifestyle Brand with Fast-Acting Cannabis-Infused Beverage	21/21/21	CI
Emerald Health Therapeutics : Tbd30's Manager Takes Stabilization Measures Following Stockholm Listing	06/21/06	MT
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	31/21/31	CI
Emerald Health Therapeutics, Inc. Enters into A License Agreement with FlowerPod LLC	06/21/06	CI
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	03/21/03	CI
Emerald Health Therapeutics, Inc. Launches its New Product Line, SYNC Tabs	13/21/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Emerald Health Therapeutics, Inc. Toronto S.E.

Equities

EMH

CA29102R1064

Highlights

Filters